Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation

Metaplastic breast cancer (MpBC) is an extremely rare breast cancer subtype, characterized by a heterogeneous phenotype. MpBC aggressive biology is attributed to its stem cell-like characteristics. Since these tumors are largely chemoresistant, novel targeted therapies should be explored. Herein, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Rishi, Koenig, Kimberly, Rohren, Eric, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197360/
https://www.ncbi.nlm.nih.gov/pubmed/25320628
http://dx.doi.org/10.4048/jbc.2014.17.3.287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197360/
https://www.ncbi.nlm.nih.gov/pubmed/25320628
http://dx.doi.org/10.4048/jbc.2014.17.3.287

Ejemplares similares